Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
about
Assessment of treatment response in tuberculosisMycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferationMatrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral TherapyGender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis.Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidityAntimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis.Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.Induced sputum is safe and well-tolerated for TB diagnosis in a resource-poor primary healthcare settingNeutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary TuberculosisLesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot StudyHeme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study.The effectiveness of sputum pH analysis in the prediction of response to therapy in patients with pulmonary tuberculosisCathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary TuberculosisPulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.Chemokines in tuberculosis: the good, the bad and the ugly.Monocyte Adhesion, Migration, and Extracellular Matrix Breakdown Are Regulated by Integrin αVβ3 in Mycobacterium tuberculosis Infection.Early Secretory Antigenic Target-6 Drives Matrix Metalloproteinase-10 Gene Expression and Secretion in TuberculosisInhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model.Tuberculosis and lung damage: from epidemiology to pathophysiology.Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPDElevated interleukin-6 and bronchiectasis as risk factors for acute exacerbation in patients with tuberculosis-destroyed lung with airflow limitation
P2860
Q28384421-7514898C-7959-4D6C-A611-9949A62E4D3EQ28385840-AB73D486-0D1A-4E44-9340-A29CCF24ECDCQ28389802-D44F500D-7B3D-4ACF-9B44-4A1CE1625EFEQ30371254-9D2707EF-CCD5-416D-9FF7-AA9432B1534CQ33702620-2A0E27E2-0E5D-4D4E-BB84-97DE28CBB914Q34058316-07C06C95-1E6A-4A77-BCC0-291C393628D9Q34480272-3B177DDE-67ED-4DC8-89CA-C51087E8061BQ35150367-F25F4D02-6DED-4E9A-BDDB-FD6CCFFD5876Q35634195-ECADB4DA-F08B-4541-9E7F-38279ADC5878Q35680564-4B50EBF6-3C20-494C-9C76-BC9017E21D72Q36031524-5C394CBF-36A7-4101-8935-703B8839DE68Q36195750-E134EB22-9FE6-415E-B94D-698A5C174980Q36350734-3F7FB99C-D065-4A03-9E8F-9B9770A7F83FQ36487876-36562C79-9DA1-4C62-9601-40713F93F8B2Q37521554-20211996-297E-4962-B3CA-C006BFC9F763Q37628903-ADA2B151-4C4D-40A9-B04F-B1B2650DBED4Q38274693-7C385FCF-AC69-40CD-A05C-5C30592F84B3Q38711285-880DAFA9-9AB2-4B26-A9B4-E928E024507AQ38921337-EF90972C-44BC-4CF9-821E-E4D908709444Q47102368-93ACE515-EEE4-49AD-AA39-D1BDA636D8ABQ54264691-2B2B62E0-963E-4C0B-A782-76590EC57CCFQ58694600-C4925357-ED06-406C-A526-1ECE63E55843Q58770879-27E12F9B-83DB-47B5-88DD-D86DB698EE4E
P2860
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@ast
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@en
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@nl
type
label
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@ast
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@en
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@nl
prefLabel
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@ast
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@en
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@nl
P2093
P2860
P50
P1433
P1476
Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis.
@en
P2093
David A J Moore
Eduardo Gotuzzo
Jon S Friedland
Liku B Tezera
P2860
P304
P356
10.1371/JOURNAL.PONE.0061333
P407
P577
2013-04-22T00:00:00Z